RACHELLE BARTHELEMY: Open Payments
NPI 1285173278 · BARBOURSVILLE, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,094 in 51 payments from 13 companies in 2025. Trend: 2023 $344 · 2024 $385 · 2025 $1,094
Food & beverage: $1,094
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $400 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $167 |
| Ardelyx, Inc. | 5 | $115 |
| Janssen Biotech, Inc. | 3 | $71 |
| Aimmune Therapeutics, Inc. | 3 | $61 |
| QOL Medical, LLC | 2 | $60 |
| Madrigal Pharmaceuticals | 2 | $52 |
| Ipsen Biopharmaceuticals, Inc | 2 | $47 |
| Braintree Laboratories, Inc. | 2 | $47 |
| Abbott Laboratories | 1 | $22 |
Products named: RINVOQ, ENTYVIO, IBSRELA, SKYRIZI, TREMFYA, LINZESS, ZENPEP, Sucraid.
Industry payments across WV — which companies pay providers there.
